356 related articles for article (PubMed ID: 32852895)
21. Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion.
Barros Romão CMDS; Santos Júnior CJD; Leite LAC; Gomes Alves MJR; Araújo NS; Castro AFL; Moura MS; Gomes VMDS; Sampaio Batinga AMC; Queiroz JAS; Dos Santos NB
Am J Case Rep; 2017 Jun; 18():692-695. PubMed ID: 28635683
[TBL] [Abstract][Full Text] [Related]
22. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
23. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
24. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
Awasthi NP; Qayoom S; Dabadghao S
J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
[TBL] [Abstract][Full Text] [Related]
25. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Sun J; Yang M; Wang L; Jin J
Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
[TBL] [Abstract][Full Text] [Related]
26. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
27. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
28. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
29. Cytomorphological and immunophenotypic characteristics of blastic plasmacytoid dendritic cell neoplasm involving central nervous system: a case report and review of literature.
Prasad T; Pushpam D; Chopra A
Cytopathology; 2022 Jul; 33(4):522-529. PubMed ID: 35119790
[TBL] [Abstract][Full Text] [Related]
30. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
31. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
32. A case report: Blastic plasmacytoid dendritic cell neoplasm is misdiagnosed as breast infiltrating ductal carcinoma.
Chen KC; Su TC; Chen DR; Liou JH
Int J Surg Pathol; 2015 Feb; 23(1):84-8. PubMed ID: 25297609
[TBL] [Abstract][Full Text] [Related]
33. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
34. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
Purkait S; Gupta S; Bakhshi S; Mallick S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
[TBL] [Abstract][Full Text] [Related]
35. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
[TBL] [Abstract][Full Text] [Related]
36. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
37. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
38. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report.
Florescu AM; Sørensen ALT; Nielsen HV; Tolnai D; Sjö LD; Larsen KL; Al-Karagholi MA
BMC Neurol; 2022 Jun; 22(1):233. PubMed ID: 35751052
[TBL] [Abstract][Full Text] [Related]
39. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
40. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.
Tang H; Panse G; Braddock D; Perincheri S; Xu ML; McNiff JM
J Cutan Pathol; 2023 Jul; 50(7):595-600. PubMed ID: 37082914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]